FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Dorsal Root Ganglion Stimulator For Pain Relief

PMA: P150004 · Supplement: S093 · Decision Mar 13, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P150004 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Dorsal Root Ganglion Stimulator For Pain Relief
Trade Name
Proclaim™ Doral Root Ganglion (DRG) IPG
PMA Number
P150004
Supplement Number
S093
Device Class
FDA Class 3
Product Code
PMP
Generic Name
Dorsal root ganglion stimulator for pain relief
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
March 13, 2026
Date Received
February 13, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

approval to consolidate manufacturing activities from two manufacturing facilities into a single manufacturing facility and to utilize new equipment at the consolidated manufacturing facility

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PMP Dorsal Root Ganglion Stimulator For Pain Relief